4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-25-000021
President & CEO gave up 22,217 shares (to pay taxes)
- President & CEO acquired 223,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hirsch Andrew · President & CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-14 | Grant or award : show line 1 in the form | +223,500 | 445,362 | D | ||
| 2025-02-14 | Shares withheld for taxes : show line 2 in the form | −12,847 | $3.18 | $40,853 | 432,515 | D |
| 2025-02-15 | Shares withheld for taxes : show line 3 in the form | −9,370 | $3.18 | $29,797 | 423,145 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-14 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +335,300 | 335,300 | D |
Loading xslF345X05/wk-form4_1739915729.xml…